Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $9.9000 (6.57%) ($9.9000 - $9.9000) on Mon. Mar. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.4% (three month average) | RSI | 22 | Latest Price | $9.9000(6.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3.7% a day on average for past five trading days. | Weekly Trend | CGEN declines -14.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(72%) ARKK(69%) IWO(67%) IBB(65%) | Factors Impacting CGEN price | CGEN will decline at least -2.2% in a week (0% probabilities). VIXM(-45%) VXX(-40%) UUP(-21%) IGOV(-6%) TBT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.2% (StdDev 4.4%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.63(-207.37%) | Inflection Point | Yes | Resistance Level | $12.12 | 5 Day Moving Average | $9.78(1.23%) | 10 Day Moving Average | $11.15(-11.21%) | 20 Day Moving Average | $12.12(-18.32%) | To recent high | -30.3% | To recent low | 10.5% | Market Cap | $819m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |